Medigus Appoints Gilad Mamlok As New CFO
OMER, Israel, July 20, 2015 – Medigus Ltd. (Nasdaq: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization technologies, announced that it has appointed Gilad Mamlok as Chief Financial Officer effective August 1st, 2015.
Mr. Mamlok brings over two decades of financial management and business development experience to his new role at Medigus. He previously was at the helm of corporate financial planning, including leading mergers and acquisitions, investor relations and corporate governance, for several public and private medical device and technology companies located in Israel and the United States. Most recently, Mr. Mamlok served as Vice President of Finance at Covidien plc, following its acquisition of Given Imaging, where he was Senior Vice President, Global Finance and Accounting since 2005.
“Medigus is delighted to welcome Gilad to our executive team, as our organization will benefit from his vast experience in global financial strategy and management,” said Chris Rowland, Chief Executive Officer of Medigus. “In his prior roles, Gilad has proven himself as a key member of leadership teams – driving finance, mergers and acquisitions, strategic deal making and business development. His extensive experience will provide critical support for the advancement of Medigus as a global commercial organization.”
“I am excited to join the leadership team of this dynamic company, which I believe is poised for significant growth reflecting demand for its innovative gastrointestinal and microvisual technology products,” said Mr. Mamlok. “I look forward to helping Medigus maximize shareholder value and realize its commercial potential.”
Mr. Oded Yatzkan, the Company’s long-time CFO, is assuming the newly-created position of Vice President, Director of Finance & Accounting, and will assist Mr. Mamlok in the transition, as well as focus on the Company’s controllership, treasury reporting and economic strategy.